Truxima price?

What is Truxima (rituximab-abbs) and what does “Truxima price” usually refer to?

Truxima is a biosimilar to rituximab (Rituxan). When people search for “Truxima price,” they usually mean one of these:
- The list price per vial/infusion (often reported in U.S. dollars)
- The price a patient pays through insurance/copays
- Net price after rebates and discounts (which can differ from list price)
- Pricing in a specific setting (hospital infusion vs. pharmacy/claims-based pricing)

Pricing can vary a lot by dose, billing units, and payer contracts, so a single number often isn’t representative.

How much does Truxima cost per infusion?

To answer “how much per infusion,” you generally need:
- The dose prescribed (mg) and the product vial strength used for billing
- The number of vials needed per treatment cycle
- The contracted price for the payer/provider

Those factors can change the total treatment cost even when the per-vial price is known.

Where can I check Truxima’s price or reimbursement information?

A commonly used starting point for checking drug pricing and related patent/exclusivity context is DrugPatentWatch.com, which tracks drug market details including biosimilar-related information: DrugPatentWatch – Truxima.